Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03173339Completed
Randomised trial of remifentanil in pain (2 arms). Primary endpoint: Number of participants with sore throat at 24 hours. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03173339.